Vimarsana
Biggest News Aggregation in the World

Page 2 - Xiuning Le News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xiuning Le. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xiuning Le Today - Breaking & Trending Today

Dr Le on the Investigation of Osimertinib and Chemotherapy in Metastatic Lung Cancer - Vimarsana News

Dr Le on the Investigation of Osimertinib and Chemotherapy in Metastatic Lung Cancer

Xiuning Le, MD, PhD, discusses ongoing and future investigations with osimertinib and chemotherapy in patients with metastatic lung cancer.

Lung Cancer Research Foundation Announces 2022 Scientific Research Grant Awards - Vimarsana News

Lung Cancer Research Foundation Announces 2022 Scientific Research Grant Awards

/PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) is pleased to announce the awardees of its 2022 Scientific Grant Program. This years' grant cycle...

Lung Cancer Research Foundation and MET Crusaders Announce Research Grant Awards - Vimarsana News

Lung Cancer Research Foundation and MET Crusaders Announce Research Grant Awards

/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) and MET Crusaders are pleased to announce funding of three grants focused on MET alteration-specific...

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients wi - Vimarsana News

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients wi

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled: High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer (N...

Spectrum Pharmaceuticals, Inc.: Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022 - Vimarsana News

Spectrum Pharmaceuticals, Inc.: Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled: High Activity of